High levels of MCL-1 expression are induced by FLT3 mutations in AML and are correlated with venetoclax resistance, leukemia relapse, and poor outcomes, suggesting a prominent role of MCL-1 as an anti-apoptotic protein in AML [53,54,55]. Here, MCL1 is linked to acute myeloid leukemia.